Miravitlles M - Search Results

1

Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature.

Doll H, Miravitlles M. Doll H, et al. Among authors: miravitlles m. Pharmacoeconomics. 2005;23(4):345-63. doi: 10.2165/00019053-200523040-00005. Pharmacoeconomics. 2005. PMID: 15853435 Review.

2

[Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care].

Miravitlles M, Murio C, Guerrero T, Segú JL. Miravitlles M, et al. Arch Bronconeumol. 1999 Apr;35(4):173-8. doi: 10.1016/s0300-2896(15)30274-x. Arch Bronconeumol. 1999. PMID: 10330538 Spanish.

3

[Recommendations for the care of the patient with chronic obstructive pulmonary disease].

Alvarez-Sala J, Cimas E, Masa J, Miravitlles M, Molina J, Naberan K, Simonet P, Viejo J; Grupo de Trabajo de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR); Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Alvarez-Sala J, et al. Among authors: miravitlles m. Arch Bronconeumol. 2001 Jul-Aug;37(7):269-78. doi: 10.1016/s0300-2896(01)75089-2. Arch Bronconeumol. 2001. PMID: 11481057 Spanish. No abstract available.

4

Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group.

Miravitlles M, Murio C, Guerrero T. Miravitlles M, et al. Eur Respir J. 2001 May;17(5):928-33. doi: 10.1183/09031936.01.17509280. Eur Respir J. 2001. PMID: 11488328

5

The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.

Miravitlles M, Ros F, Cobos A, Kubin R, Tillotson G. Miravitlles M, et al. Int J Clin Pract. 2001 Sep;55(7):437-41. Int J Clin Pract. 2001. PMID: 11594251 Clinical Trial.

6

[The cost of chronic obstructive pulmonary disease in Spain: options for optimizing resources].

Miravitlles M, Figueras M. Miravitlles M, et al. Arch Bronconeumol. 2001 Oct;37(9):388-93. doi: 10.1016/s0300-2896(01)78820-5. Arch Bronconeumol. 2001. PMID: 11674939 Spanish. No abstract available.

7

Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.

Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Miravitlles M, et al. Chest. 2002 May;121(5):1449-55. doi: 10.1378/chest.121.5.1449. Chest. 2002. PMID: 12006427

8

Treatment and quality of life in patients with chronic obstructive pulmonary disease.

Miravitlles M, Alvarez-Sala JL, Lamarca R, Ferrer M, Masa F, Verea H, Zalacain R, Murio C, Ros F; IMPAC Study Group. Miravitlles M, et al. Qual Life Res. 2002 Jun;11(4):329-38. doi: 10.1023/a:1015520110663. Qual Life Res. 2002. PMID: 12086118

9

Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease.

Miravitlles M. Miravitlles M. Eur Respir J. 2002 Jul;20(1):243-4. doi: 10.1183/09031936.02.01302001. Eur Respir J. 2002. PMID: 12166576 No abstract available.

10

Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?

Miravitlles M. Miravitlles M. Eur Respir J Suppl. 2002 Jul;36:9s-19s. doi: 10.1183/09031936.02.00400302. Eur Respir J Suppl. 2002. PMID: 12168752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results